FDBusiness.com

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease

 Breaking News
  • Hilton Food Group to Move into UK Fish Processing Hilton Food Group, the UK-based specialist international meat packing business, has agreed to acquire Icelandic Group UK (Seachill), a leading chilled UK fish processor, for cash consideration of £80.8 million. The acquisition will provide Hilton with entry into the processing and supply of fish in the UK. Robert Watson OBE, chief executive of Hilton Food Group. Founded [...]...
  • UK Health Costs of Obesity Soaring Money spent last year on junk food advertising in the UK far outweighs the amount Government is able to spend on healthy eating campaigns, leading to an unbalanced environment pushing us towards unhealthy choices, according to new analysis by the Obesity Health Alliance (OHA). Junk food brands are spending 27.5 times more on advertising their products [...]...
  • The End of EU Sugar and Isoglucose Quotas Will Benefit All Stakeholders EU sugar and isoglucose production quotas ended on 30 September 2017. At its recent conference at the Bibliothèque Solvay in Brussels, Starch Europe called on all stakeholders to embrace the benefits of this historic development. Speaking at the conference, Starch Europe president, Alain Dufait said: “As an industry, we find ourselves in a time of opportunity. [...]...
  • Scotbeef Purchases Blast Freezer From Blue Cube In a move to boost freezer capacity at its modern plant in Glasgow, leading UK fresh meat processing company, Scotbeef has purchased a BFT40 portable blast freezer from Blue Cube Portable Cold Stores – part of The Turner Group – after renting the unit for several years. Scotbeef is one of the largest privately owned fresh [...]...
  • Kasih Food Revitalises Hummus Range For International Market Kasih Food Production Co, a leading food production company in Jordan, has unveiled a new range of hummus products in Tetra Pak packages. With the new Mézete brand product line, the company aims to increase its share of the hummus market, projected to reach US$1.1 billion globally by 2022, according to Market Research Future. That [...]...

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease
September 28
10:15 2015

The Nestlé Institute of Health Sciences SA (NIHS), a fundamental research institute of the global nutrition, health and wellness company Nestlé, has signed a research collaboration agreement with AC Immune SA – a leading Lausanne-based biopharmaceutical company focused on neurodegenerative diseases. The aim of the collaboration is to develop a sensitive, minimally invasive Tau diagnostic assay for early Alzheimer’s disease (AD) by applying Nestlé’s proprietary multiplexed ultrasensitive antibody technology platform.

Tangles of Tau proteins are recognised as one of two major hallmarks of neurodegeneration, the other being beta-amyloid (Abeta) plaques. Tangles and other abnormal forms of Tau protein accumulate inside the brain cells and spread between cells of people with Alzheimer’s disease over a long period of time. It is now well established that Tau correlates well with cognitive decline and disease progression. Furthermore, Tau may develop into a suitable biomarker for early diagnosis of the disease.

“This collaboration agreement opens up exciting new possibilities in the quest to better understand and combat this debilitating disease,” comments Ed Baetge, Head of NIHS. “By bringing together our ultrasensitive next-generation diagnostic platform and AC Immune’s expertise in the field, we hope to develop a minimally invasive Tau diagnostic using patients’ blood which can identify Alzheimer’s patients at a very early, and potentially pre-symptomatic, stage of the disease.”

Andrea Pfeifer, CEO of AC Immune, comments: “The development of a minimally invasive diagnostic test to identify patients at very early stages is considered as one of the most pressing needs in the treatment of Alzheimer’s disease.”

Ed Baetge adds: “Our overarching goal at NIHS is to develop nutritional approaches and technologies that help people maintain or improve their cognitive vigour especially for early diagnosis and targeted intervention to combat this global health problem.”

Nestlé’s technology is a patented diagnostic antibody-based platform capable of measuring soluble proteins with high sensitivity and specificity. The technology was developed by Prometheus Laboratories In., a Nestlé Health Science company. Since 2013, NIHS has applied it in Brain Health research, specifically in Alzheimer’s. The assay uses a triplex antibody microarray-based platform that measures the expression and activation of target proteins in tissues, blood or other fluids.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • October 19, 2017PMA Fresh Summit 2017
  • October 21, 2017Food & Nutrition Conference & Expo 2017
  • October 22, 2017Serbotel
  • October 22, 2017Natexpo
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements